What type of study is this?

September 10, 2025Journal of Clinical & Translational OphthalmologyOpen Access

Seven-Year Outcomes of Aflibercept in Neovascular Age-Related Macular Degeneration in a Teaching Hospital Setting

View Full Paper

Ask AI

Bookmark

Authors

ABAntoine Barloy FBFlorent Boulanger BJBenjamin JanyEindhoven University of Technology

Discussion

Member takes

Implication

Retrospective analysis finds visual acuity declines in patients treated for neovascular age-related macular degeneration, highlighting monitoring deficiencies.

Key Points

Visual acuity declined by −12.3 letters at seven years, showing a long-term impact of treatment for neovascular age-related macular degeneration.
Among 116 eyes, 44.8% completed the seven-year follow-up; 57.7% maintained stable BCVA with less than a 15-letter loss during this period.
Retrospective, single-center analysis indicates significant changes in central retinal thickness and a high incidence of macular atrophy over seven years.
The study underscores the need for improved patient monitoring in teaching hospitals to enhance outcomes in neovascular age-related macular degeneration.

Cite This Study

Barloy et al. (2025) studied this question.

synapsesocial.com/papers/68c1a12d54b1d3bfb60dc35b https://doi.org/10.3390/jcto3030014

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis finds visual acuity declines in patients treated for neovascular age-related macular degeneration, highlighting monitoring deficiencies.

Seven-Year Outcomes of Aflibercept in Neovascular Age-Related Macular Degeneration in a Teaching Hospital Setting

Discussion

Member takes

Implication

Key Points

Cite This Study

Seven-Year Outcomes of Aflibercept in Neovascular Age-Related Macular Degeneration in a Teaching Hospital Setting

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider